SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.06500.0%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Howard Williams7/18/2013 8:51:29 AM
  Read Replies (3) of 13111
 
Provectus Exhibits At 8th World Congress of Melanoma
Thursday July 18, 2013



Provectus is a sponsor and exhibitor at the 8th World Congress of Melanoma being held on July 17-20 in Hamburg, Germany.

On Thursday July 18, 9:20 AM CET, Professor Nikolas Haass of the University of Quensland will be giving a presentation entitled "Rose Bengal - phototoxicity versus intrinsic cytotoxicity" during a free communications session on melanoma treatment.

On Thursday July 18, 3:00 PM CET, Dr. Sanjiv Agarwala of St. Luke's University and Health Network will be giving a presentation entitled "Current perspectives on intralesional therapies" at a satellite symposium.

On Friday July 19, 11:26 AM CET, Professor John Thompson of the University of Sydney will be giving a presentation entitled "Limb perfusion / PV-10" as part of a symposium entitled "Loco regional melanoma treatment".

Additional information on these presentations is expected to be provided next week.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext